Abstract
Growth failure in children with high growth hormone (GH) levels, low insulin-like growth factor 1 (IGF-1) levels, and accelerated linear growth in response to exogenous GH is presumed to result from biologically inactive GH. A molecular diagnosis has only been made in two such patients. We analyzed the presentations and the GH-1 genes of twin Egyptian brothers with this phenotype. At 8 yr of age, the boys’ heights were −4 SD. Their IGF-1 levels were 64 and 60 ng/mL, baseline GH levels were 2.1 and 11.7 mU/L, and growth hormone binding protein levels were normal. Twin B attained a peak GH level of 30.6 mU/L after l-dopa stimulation (Twin A was not tested). After 1 yr of exogenous GH, their growth velocities were >11 cm/year (>97%). Analysis of their GH-1 exons and introns revealed no mutations, but five polymorphisms were identified that have not been previously reported. The GH-1 DNA sequence was transfected into human cells and the resulting GH-1 transcripts were analyzed. Wildtype GH-1 mRNAs were observed, demonstrating that the polymorphisms do not affect transcript processing. Therefore, although no evidence of GH-1 gene mutations or abnormal GH-1 mRNA processing was found, the subjects’ excellent response to exogenous GH supports a trial of GH in children with severe short stature, low IGF-1 levels and normal GH responses to stimulation testing.
Similar content being viewed by others
References
Kowarski, A. A., Schneider, J., Ben-Galim, E., Weldon, V. V., and Daughaday, W. H. (1978). J. Clin. Endocrinol. Metab. 47, 461–464.
Rudman, D., Kutner, M. H., Blackston, R. D., Cushman, R. A., Bain, R. P., and Patterson, J. H. (1981). N. Engl. J. Med. 305, 123–131.
Bright, G. M., Rogol, A. D., Johanson, A. J., and Blizzard, R. M. (1983). Pediatrics 71, 576–580.
Frazer, T., Gavin, J. R., Daughaday, W. H., Hillman, R. E., and Weldon, V. V. (1982). J. Pediatr. 101, 12–15.
Plotnick, L. P., Van Meter, Q. L., and Kowarski, A. A. (1983). Pediatrics 71, 324–327.
Takahashi, Y., Kaji, H., Okimura, Y., Goji, K., Abe, H., and Chihara, K. (1996). N. Engl. J. Med. 334, 432–436.
Takahashi, Y., Shirono, H., Arisaka, O., et al. (1997). J. Clin. Invest. 100, 1159–1165.
Valenta, L. J., Sigel, M. B., Lesniak, M. A., et al. (1985). N. Engl. J. Med. 312, 214–217.
Binder, G., Benz, M. R., Elmlinger, M., Pflaum, C. D., Strasburger, C. J., and Ranke, M. B. (1999). Clin. Endocrinol. (Oxf.) 51, 89–95.
Goddard, A. D., Covello, R., Luoh, S. M., et al. (1995). N. Engl. J. Med. 333, 1093–1098.
Kou, K., Lajara, R., and Rotwein, P. (1993). J. Clin. Endocrinol. Metab. 76, 54–59.
Iida, K., Takahashi, Y., Kaji, H., et al. (1998). J. Clin. Endocrinol. Metab. 83, 531–537.
Ayling, R. M., Ross, R., Towner, P., et al. (1997). Nat. Genet. 16, 13–14.
Shen, L. X., Basilion, J. P., and Stanton, V. P. (1999). Proc. Natl. Acad. Sci. USA 96, 7871–7876.
Le Stunff, C., Fallin, D., Schork, N. J., and Bougneres, P. (2000). Nat. Genet. 26, 444–446.
Baumann, G. (1991). Horm. Res. 36(Suppl. 1), 5–10.
Garcia-Barros, M., Costoya, J. A., Rios, R., Arce, V., and Devesa, J. (2000). Horm. Res. 53, 40–45.
Haro, L. S., Lewis, U. J., Garcia, M., Bustamante, J., Martinez, A. O., and Ling, N. C. (1996). Biochem. Biophys. Res. Commun. 228, 549–556.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Walvoord, E.C., Sloop, K.W., Dwyer, C.J. et al. Severe short stature and endogenous growth hormone resistance in twin brothers without growth hormone gene mutations. Endocr 21, 289–295 (2003). https://doi.org/10.1385/ENDO:21:3:289
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1385/ENDO:21:3:289